elsevier global medical news Videos

. Christopher Zachary describes a face-off comparison of 4 different fractionated laser systems in the treatment of wrinkles and scars on live patients at a cosmetic dermatology meeting sponsored by the Skin Disease Education Foundation. Dr. Zachary is professor and chair of dermatology, University of California, Irvine. Betsy Bates of the Global Medical News Network (GMNN) reports. (SDEF and GMNN are owned by Elsevier, Inc.) ... GMNN SDEF "cosmetic surgery" "plastic surgery" "scar removal ...

Author: SkinAndAllergyNews; Tags: GMNN SDEF cosmetic surgery plastic surgery scar removal facelift

. Christopher Zachary describes a face-off comparison of 4 different fractionated laser systems in the treatment of wrinkles and scars on live patients at a cosmetic dermatology meeting sponsored by the Skin Disease Education Foundation. Dr. Zachary is professor and chair of dermatology, University of California, Irvine. Betsy Bates of the Global Medical News Network (GMNN) reports. (SDEF and GMNN are owned by Elsevier, Inc.) ... GMNN SDEF "cosmetic surgery" "plastic surgery" "scar removal ...

Author: ElsGlobalMedicalNews; Tags: GMNN SDEF cosmetic surgery plastic surgery scar removal facelift

The already rapidly evolving array of cosmetic dermatology products is about to expand again, speakers said at a cosmetic dermatology seminar sponsored by the Skin Diseae Education Foundation. Dysport, ArteFill, Juvéderm with lidocaine, and others are on the horizon in the US Betsy Bates of Global Medical News Network (GMNN) interviews Dr. David Goldberg. (SDEF and GMNN are owned by Elsevier, Inc.)

Author: SkinAndAllergyNews; Tags: GMNN SDEF cosmetic surgery plastic surgery scar removal

The already rapidly evolving array of cosmetic dermatology products is about to expand again, speakers said at a cosmetic dermatology seminar sponsored by the Skin Diseae Education Foundation. Dysport, ArteFill, Juvéderm with lidocaine, and others are on the horizon in the US Betsy Bates of Global Medical News Network (GMNN) interviews Dr. David Goldberg. (SDEF and GMNN are owned by Elsevier, Inc.)

Author: ElsGlobalMedicalNews; Tags: GMNN SDEF cosmetic surgery plastic surgery scar removal

Dr. George L. Bakris reports that two aldosterone receptor blocking drugs spironolactone and eplerenone have swiftly become important, second-line antihypertensive drugs for obese patients. Mitchel Zoler of Elsevier Global Medical News (EGMN) reports from a meeting of the American Diabetes Association in New York.

Author: FamilyPracticeNews; Tags: aldosterone receptor blocking drugs spironolactone eplerenone obese obesity hypertension antihypertensive EGMN

Dr. George L. Bakris reports that two aldosterone receptor blocking drugs spironolactone and eplerenone have swiftly become important, second-line antihypertensive drugs for obese patients. Mitchel Zoler of Elsevier Global Medical News (EGMN) reports from a meeting of the American Diabetes Association in New York.

Author: InternalMedicineNews; Tags: 64673 aldosterone receptor blocking drugs spironolactone eplerenone obese obesity hypertension antihypertensive EGMN

Dr. George L. Bakris reports that two aldosterone receptor blocking drugs spironolactone and eplerenone have swiftly become important, second-line antihypertensive drugs for obese patients. Mitchel Zoler of Elsevier Global Medical News (EGMN) reports from a meeting of the American Diabetes Association in New York.

Author: ClinicalEndoNews; Tags: aldosterone receptor blocking drugs spironolactone eplerenone obese obesity hypertension antihypertensive EGMN

Dr. George L. Bakris reports that two aldosterone receptor blocking drugs spironolactone and eplerenone have swiftly become important, second-line antihypertensive drugs for obese patients. Mitchel Zoler of Elsevier Global Medical News (EGMN) reports from a meeting of the American Diabetes Association in New York.

Author: CardiologyNews; Tags: aldosterone receptor blocking drugs spironolactone eplerenone obese obesity hypertension antihypertensive EGMN

Dr. George L. Bakris reports that two aldosterone receptor blocking drugs spironolactone and eplerenone have swiftly become important, second-line antihypertensive drugs for obese patients. Mitchel Zoler of Elsevier Global Medical News (EGMN) reports from a meeting of the American Diabetes Association in New York.

Author: ElsGlobalMedicalNews; Tags: aldosterone receptor blocking drugs spironolactone eplerenone obese obesity hypertension antihypertensive EGMN

Dr. Harold J. Wanebo reports that a neoadjuvant regimen of cetuximab and chemoradiation was linked to significant downstaging of locally advanced esophageal cancer. Bob Finn of Elsevier Global Medical News (EGMN) reports from a meeting on gastrointestinal cancer sponsored by the American Society of Clinical Oncology.

Author: ElsGlobalMedicalNews; Tags: cetuximab chemoradiation esophageal cancer EGMN ASCO